Identification of a rare p.G320R alpha-1-antitrypsin variant in emphysema and lung cancer patients
2010

Rare Alpha-1-Antitrypsin Variant in Lung Disease

Sample size: 21 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ljujic Mila, Aleksandra Topic, Nikolic Aleksandra, Divac Aleksandra, Grujic Milan, Mitic-Milikic Marija, Radojkovic Dragica

Primary Institution: Institute of Molecular Genetics and Genetic Engineering, Belgrade

Hypothesis

Does the p.G320R variant of alpha-1-antitrypsin affect its functional activity in patients with emphysema and lung cancer?

Conclusion

The p.G320R variant is associated with reduced functional activity of alpha-1-antitrypsin protein in patients with severe pulmonary disorders.

Supporting Evidence

  • The p.G320R variant was found in two patients with severe pulmonary disorders.
  • Specific trypsin inhibitory activity was lower in both patients compared to healthy individuals.
  • The variant was previously described in a large population study.

Takeaway

Some people have a special version of a protein that helps their lungs, but this version doesn't work as well, which can make them sick.

Methodology

The study compared specific trypsin inhibitory activity in two patients with the p.G320R variant and 19 healthy individuals.

Potential Biases

Potential bias in patient selection and the retrospective nature of some data.

Limitations

The study is limited by the small sample size and the need for further confirmation of findings.

Participant Demographics

Two male patients (one 31 years old with emphysema, one 73 years old with lung cancer) and 19 healthy individuals.

Statistical Information

P-Value

null

Confidence Interval

null

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572009005000100

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication